About ProChon Biotech
ProChon Biotech is a company based in Rehovot (Israel) founded in 1996 was acquired by Histogenics in May 2011. ProChon Biotech operates in a competitive market with competitors including Horizon Therapeutics, Ensoma, Tenaya Therapeutics, Orca Bio and Athira Pharma, among others.
- Headquarter Rehovot, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$3.95 M (USD), Debt – Convertible
Jan 20, 2010
- Investors
-
Employee Count
Not available
-
Acquired by
Histogenics
(May 16, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ProChon Biotech
Investors in ProChon Biotech
ProChon Biotech has secured backing from 1 investor. Prominent investors backing the company include Histogenics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Restorative cell therapies for orthopedic diseases are developed.
|
Locked | Locked | Locked |
Investor details for ProChon Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ProChon Biotech
Investment portfolio details for ProChon Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ProChon Biotech
Detailed financials for ProChon Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prochon Biotech Comparisons
Peer comparison for ProChon Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ProChon Biotech
ProChon Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Ensoma, Tenaya Therapeutics, Orca Bio and Athira Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drugs for treating rare and autoimmune diseases
|
|
| Locked | Locked | Locked |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| Locked | Locked | Locked |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| Locked | Locked | Locked |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| Locked | Locked | Locked |
Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed.
|
|
| Locked | Locked | Locked |
Restorative cell therapies for orthopedic diseases are developed.
|
Detailed competitors of ProChon Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prochon Biotech
Complete news archive for ProChon Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ProChon Biotech
ProChon Biotech was founded in 1996 and raised its 1st funding round 14 years after it was founded.
ProChon Biotech is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
ProChon Biotech develops and commercializes regenerative biology-based products for acute and chronic articular cartilage focal lesions. The company focuses on modulating the fibroblast growth factor system to enable it to create solutions for tissue regeneration. It offers orthobiologic therapeutic solutions, including BioCart Autologous Cartilage Regeneration system, a solution for the restoration of articular cartilage lesions that results in the regeneration of hyaline-like tissue. It was acquired by Histogenics in May, 2011.
ProChon Biotech's top competitors include Horizon Therapeutics, Tenaya Therapeutics and Athira Pharma.
ProChon Biotech has 1 investor. Key investors include Histogenics.